In recent years, technological innovations such as insulin pump therapy and continuous glucose monitoring (CGM) systems have emerged to improve diabetes management, leading to a reduction in the risk of hypoglycemia, particularly severe hypoglycemia [2,4,5]. The gene discussed is INS; the disease is Hypoglycemia.